Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$16.60 - $28.47
Next Earnings Date
May 07 2025
Next Earnings Date
May 07 2025
Latest price
Market Cap | $1.86B |
EV | $1.63B |
Shares Outstanding | 73.04M |
Beta | 1.77 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $31.78 |
P/E 2025E | - |
P/Revenue 2025E | 7.36x |
Revenue | 14.60% |
EPS | -21.90% |
Operating Cash Flow | -30.60% |
Free Cash Flow | -28.40% |
Revenue | 21.20% |
EPS | 21.80% |
Operating Cash Flow | - |
Free Cash Flow | 21.50% |
Gross Margin 2025E | 58.73% |
Net Profit Margin 2025E | -74.65% |
ROE 2025E | -44.81% |
ROCE 2024 | -38.58% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Schrödinger, Inc.
SDGR
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Farid, Ramy
Employees
891
Website
www.schrodinger.comIPO Date
2020-02-06
Headquarters
1540 Broadway, 24th Floor, New York, New York, 10036, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved